Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Daily News

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Yael L. Maxwell

November 10, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Conference News ACC 2022

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

Todd Neale

April 02, 2022

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

New Advanced Training Outlined for Future Vascular Medicine Specialists

Michael O'Riordan

January 21, 2021

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Daily News

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Shelley Wood

April 06, 2018

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

News Daily News

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Michael O'Riordan

April 04, 2017

Advertisement

December 2025 Dispatch for the CV Team

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

October 2025 Dispatch for the CV Team

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

May 2024 Dispatch for the CV Team

October 2023 News Roundup

AHA Scientific Statement Addresses Health Disparities in PAD

Only Half of Revascularized PAD Patients Receive GDMT

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

March 2021 News Roundup

New Advanced Training Outlined for Future Vascular Medicine Specialists

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content